Clinical Resources

Potential stem cell-derived therapies are advancing from the laboratory towards the clinic. These cell-based approaches present novel considerations for clinicians and the public alike. The ISSCR is dedicated to helping educate and inform clinicians, review boards, and the public with current, scientifically-grounded information on these advances and their application(s).




Guidelines that outline core principles of scientific rigor and research integrity, regularly updated based on scientific developments and disseminated to researchers, clinicians, organizations and institutions around the world.


The ISSCR Urges HHS to Rescind the Proposed Rule on Human Fetal Tissue Research

  • 12 February, 2021
News from ISSCR website tile

94 Scientific, Medical, and Patient Organizations Sign-on to Comment Letter

The ISSCR has submitted comments urging the Department of Health and Human Services (HHS) to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). Among other key points, the letter states that the proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19.

The comments on the proposed rule come after the ISSCR and a coalition of organizations reinforced the value of human fetal tissue research in a letter to then President-Elect Biden on 7 January, 2021.

Read the comments.